BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology

Reuters08-26

Aug 26 (Reuters) - Lucid Diagnostics Inc LUCD.O:

PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBREAKING ENDOSCOPIC ESOPHAGEAL IMAGING TECHNOLOGY
PAVMED INC - LUCID DIAGNOSTICS TO PARTNER WITH PAVMED ON TECHNOLOGY
PAVMED INC - EXECUTES NON-BINDING LETTER WITH DUKE UNIVERSITY FOR TECHNOLOGY

Source text: ID:nPn7xZKWma

Further company coverage: LUCD.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2562957735?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-26 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2562957735","market":"fut","top_or_hot":-1,"title":"BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology</title></head><body><p><span>Aug 26 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/LUCD\">Lucid Diagnostics</a> Inc <span>LUCD.O</span>:</p><ul><li><p>PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBREAKING ENDOSCOPIC ESOPHAGEAL IMAGING TECHNOLOGY</p></li><li><p>PAVMED INC - LUCID DIAGNOSTICS TO PARTNER WITH PAVMED ON TECHNOLOGY</p></li><li><p>PAVMED INC - EXECUTES NON-BINDING LETTER WITH DUKE UNIVERSITY FOR TECHNOLOGY</p></li></ul><p>Source text: <span>ID:nPn7xZKWma</span></p><p>Further company coverage: <span>LUCD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-26 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging Technology</title></head><body><p><span>Aug 26 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/LUCD\">Lucid Diagnostics</a> Inc <span>LUCD.O</span>:</p><ul><li><p>PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBREAKING ENDOSCOPIC ESOPHAGEAL IMAGING TECHNOLOGY</p></li><li><p>PAVMED INC - LUCID DIAGNOSTICS TO PARTNER WITH PAVMED ON TECHNOLOGY</p></li><li><p>PAVMED INC - EXECUTES NON-BINDING LETTER WITH DUKE UNIVERSITY FOR TECHNOLOGY</p></li></ul><p>Source text: <span>ID:nPn7xZKWma</span></p><p>Further company coverage: <span>LUCD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UI054:1","article_id":"2562957735","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2562957735","pubTimestamp":1756209874,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging TechnologyAug 26 (Reuters) - Lucid Diagnostics Inc LUCD.O:PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBRE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","PAVM":"PAVmed Inc.","LUCD":"LUCID DIAGNOSTICS INC."},"translate_title":"BRIEF-Pavmed签署开创性内窥镜食管成像技术许可意向书","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LUCD":0.9,"PAVM":0.9},"content_text":"BRIEF-Pavmed Signs Letter Of Intent To License Groundbreaking Endoscopic Esophageal Imaging TechnologyAug 26 (Reuters) - Lucid Diagnostics Inc LUCD.O:PAVMED SIGNS LETTER OF INTENT TO LICENSE GROUNDBREAKING ENDOSCOPIC ESOPHAGEAL IMAGING TECHNOLOGYPAVMED INC - LUCID DIAGNOSTICS TO PARTNER WITH PAVMED ON TECHNOLOGYPAVMED INC - EXECUTES NON-BINDING LETTER WITH DUKE UNIVERSITY FOR TECHNOLOGYSource text: ID:nPn7xZKWmaFurther company coverage: LUCD.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2562957735","isCrawlerRequest":true}